Exlites Holdings International, Inc. (EXHI)
0.45
0.00 (0.00%)
USD |
OTCM |
Oct 16, 16:00
Exlites Holdings International Research and Development Expense (Annual)
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| January 31, 2022 | 0.0299M |
| January 31, 2021 | 0.0146M |
| January 31, 2020 | 0.0254M |
| Date | Value |
|---|---|
| January 31, 2019 | 0.0399M |
| January 31, 2016 | 0.275M |
| January 31, 2015 | 0.0122M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Xcelerate, Inc. | -- |
| Vivos Therapeutics, Inc. | 0.10M |
| Hinge Health, Inc. | 368.14M |
| Anika Therapeutics, Inc. | 25.77M |
| Enovis Corp. | 120.33M |